A genetically engineered spleen necrosis virus-derived retroviral vector that displays the HIV type 1 glycoprotein 120 envelope peptide

Human Gene Therapy

Volumn 10, Issue 16, 1999, Pages 2627-2636

  Jiang, A N ^a   Fisher, Hugh ^a,b   Pomerantz, Roger J ^a   Dornburg, Ralph ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; VIRUS VECTOR;

ARTICLE; CONTROLLED STUDY; GENE CONSTRUCT; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC ENGINEERING; GENETIC LINKAGE; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; RETROVIRUS; VIRUS PARTICLE; VIRUS TITRATION;

ANIMALS; ANTIGENS, CD4; CD4-POSITIVE T-LYMPHOCYTES; DOGS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HELA CELLS; HIV ENVELOPE PROTEIN GP120; HIV-1; HUMANS; MEMBRANE FUSION; RECEPTORS, CXCR4; RECOMBINANT FUSION PROTEINS; SPLEEN FOCUS-FORMING VIRUSES;

CANIS FAMILIARIS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; SPLEEN NECROSIS VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0033229955     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950016663     Document Type: Article

References (40)

1. ALIZON, M., SONIGO, P., BARRÉ-SINOUSSI, F., CHERMANN, J.C., TIOLLAIS, P., MONTAGNIER, L., and WAIN-HOBSON, S. (1984). Molecular cloning of lymphadenopathy-associated virus. Nature (London) 312, 757-760.
2. ALKHATIB, G., COMBADIERE, C., BRODER, C.C., FENG, Y., KENNEDY, P.E., MURPHY, P.M., and BERGER, E.A. (1996). CC CKR5: A RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 272, 1955-1958.
3. ANDERSON, W.F. (1994). Gene therapy for AIDS. Hum. Gene Ther. 5, 149-150.
4. ANDERSON, W.F. (1998). Human gene therapy. Nature (London) 392, 25-30.
5. BERSON, J.F., and DOMS, R.W. (1998). Structure-function studies of the HIV-1 coreceptors. Semin. Immunol. 10, 237-248.
6. BLEUL, C.C., FARZAN, M., CHOE, H., PAROLIN, C., CLARK-LEWIS, I., SODROSKI, J., and SPRINGER, T.A. (1996). The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusion and blocks HIV-1 entry. Nature (London) 382, 829-833.
7. BOUR, S., GELEZIUNAS, R., and WAINBERG, M.A. (1995). The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol. Rev. 59, 63-93.
8. BRODER, C.C., and COLLMAN, R.G. (1997). Chemokine receptors and HIV. J Leukocyte Biol. 62, 20-29.
9. CHU, T.-H., and DORNBURG, R. (1995). Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer. J. Virol. 69, 2659-2663.
10. CHU, T.-H., and DORNBURG, R. (1997). Towards highly-efficient cell-type-specific gene transfer with retroviral vectors that display a single chain antibody. J. Virol. 71, 720-725.
11. CHU, T.-H., MARTINEZ, I., SHEAY, W.C., and DORNBURG, R. (1994). Cell targeting with retroviral vector particles containing antibody-envelope fusion proteins. Gene Ther. 1, 292-299.
12. CORDONNIER, A., MONTAGNIER, L., and EMERMAN, M. (1989). Single amino-acid changes in HIV envelope affect viral tropism and receptor binding. Nature (London) 340, 571-574.
13. COSSET, F.L., and RUSSELL, S.J. (1996). Targeting retrovirus entry. Gene Ther. 3, 946-956.
14. COURNOYER, D., and CASKEY, C.T. (1993). Gene therapy of the immune system. Annu. Rev. Immunol. 11, 297-329.
15. CUI, Z.-Z., LEE, L.F., SILVIA, R.F., and WITTER, R.L. (1986). Monoclonal antibodies against avian reticuloendotheliosis virus: Identification of strain-specific and strain-common epitopes. J. Immunol. 136, 4237-4242.
16. DORANZ, B.J., BERSON, J.F., RUCKER, J., and DOMS, R.W. (1997). Chemokine receptors as fusion cofactors for human immunodeficiency virus type 1 (HIV-1). Imunol. Res. 16, 15-28.
17. DORNBURG, R. (1995). Reticuloendotheliosis viruses and derived vectors. Gene Ther. 2, 301-310.
18. DORNBURG, R. (1997). From the natural evolution to the genetic manipulation of the host range of retroviruses. Biol. Chem. 378, 457-468.
19. ENGELSTÄDTER, M., BOBKOVA, M., BAIER, M., STITZ, J., KURTH, R., DORNBURG, R., BUCHHOLZ, C.J., and CICHUTEK, K. (1999). Targeting human T-cells by retroviral vectors displaying antibody domains selected from a phage display library. Hum. Gene Ther. (in press).
20. GAUTIER, R., JIANG, A., ROUSSEAU, V., DORNBURG, R., and JAFFREDO, T. (1999). The reticuloendotheliosis viruses strain A, REV-A or spleen necrosis virus, SNV, are non-infectious in human cells. (Submitted.)
21. GILBOA, E. (1990). Retroviral gene transfer: Applications to human gene therapy. Prog. Clin. Biol. Res. 352, 301-311.
22. GILMORE, T.D., and TEMIN, H.M. (1986). Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell 44, 791-800.
23. HUNTER, E., and SWANSTROM, R. (1990). Retrovirus envelope glycoproteins. Curr. Top. Microbiol. Immunol. 157, 187-253.
24. JIANG, A., and DORNBURG, R. (1999). In vivo cell-type-specific gene delivery with retroviral vectors that display single chain antibodies. Gene Ther. (in press).
25. JIANG, A., CHU, T.-H.T., NOCKEN, F., CICHUTEK, K., and DORNBURG, R. (1998). Cell-type-specific gene transfer into human cells with retroviral vectors that display single-chain antibodies. J. Virol. 72, 10148-10156.
26. KAWAI, S., and NISHIZAWA, M. (1984). New procedure for DNA transfection with polycation and dimethyl sulfoxide. Mol. Cell. Biol. 4, 1172-1174.
27. MARTINEZ, I., and DORNBURG, R. (1995). Improved retroviral packaging lines derived from spleen necrosis virus. Virology 208, 234-241.
28. MCKEATING, J.A., and WILLEY, R.L. (1989). Structure and function of the HIV envelope. AIDS 3(Suppl. 1), S35-S41.
29. MIKAWA, T., FISCHMAN, D.A., DOUGHERTY, J.P., and BROWN, A.M.C. (1992). In vivo analysis of a new lacZ retrovirus vector suitable for lineage marking in avian and other species. Exp. Cell Res. 195, 516-523.
30. MILLER, A.D. (1990). Retrovirus packaging cells. Hum. Gene Ther. 1, 5-14.
31. MILLER, A.D. (1996). Cell-surface receptors for retroviruses and implications for gene transfer. Proc. Natl. Acad. Sci. U.S.A. 93, 11407-11413.
32. MILLER, D.G., EDWARDS, R.H., and MILLER, A.D. (1994). Cloning of the cellular receptor for amphotropic murine retroviruses reveals homology to that for gibbon ape leukemia virus. Proc. Natl. Acad. Sci. U.S.A. 91, 78-82.
33. MOORE, J.P., TRKOLA, A., and DRAGIC, T. (1997). Co-receptors for HIV-1 entry. Curr. Opin. Immunol. 9, 551-562.
34. ORLIC, D., GIRARD, L.J., JORDAN, C.T., ANDERSON, S.M., CLINE, A.P., and BODINE, D.M. (1996). The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction. Proc. Natl. Acad. Sci. U.S.A. 93, 11097-11102.
35. POESCHLA, E.M., and WONG-STAAL, F. (1995). Gene therapy and HIV disease. In AIDS Clinical Review. P. Volberding and M.A. Jacobson, eds. (Marcel Dekker, Inc., New York) pp. 1-45.
36. POMERANTZ, R.J., and TRONO, D. (1995). Genetic therapies for HIV infections: Promise for the future. AIDS 9, 985-993.
37. PURCHASE, H.G., and WITTER, R.L. (1975). The reticuloendotheliosis viruses. Curr. Top. Microbiol. Immunol. 71, 103-124.
38. SCHNIERLE, B.S., STITZ, J., BOSCH, V., NOCKEN, F., MERGETMILLITZER, H., ENGELSTADTER, M., KURTH, R., GRONER, B., and CICHUTEK, K. (1997). Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells. Proc. Natl. Acad. Sci. U.S.A. 94, 8640-8645.
39. SHEAY, W., NELSON, S., MARTINEZ, I., CHU, T.-H.T., and DORNBURG, R. (1993). Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eucaryotic vectors. BioTechniques 15, 856-861.
40. SOMIA, N.V., ZOPPE, M., and VERMA, I.M. (1995). Generation of targeted retroviral vectors by using single-chain variable fragment: An approach to in vivo gene delivery. Proc. Natl. Acad. Sci. U.S.A. 92, 7570-7574.